Global Drug Discovery Outsourcing Market Forecast to 2028

創薬アウトソーシングの世界市場予測2019-2029

◆タイトル:Global Drug Discovery Outsourcing Market Forecast to 2028
◆商品コード:VGN906173
◆調査・発行会社:visiongain
◆発行日:2019年4月
◆ページ数:195
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Sigle UserGBP3,499 ⇒換算¥475,864見積依頼/購入/質問フォーム
Departmental/Five UserGBP3,899 ⇒換算¥530,264見積依頼/購入/質問フォーム
Site LicenseGBP4,999 ⇒換算¥679,864見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"創薬アウトソーシングの世界市場予測2019-2029"について調査・分析し、レポートサマリー、世界市場規模・市場予測、地域別市場分析、主要国別市場分析、市場環境分析、主要企業分析などの情報をお届けいたします。

The global drug discovery outsourcing market is estimated to have reach $22.69bn in 2018, dominated by the chemistry services segment. The global drug discovery outsourcing market is expected to grow at a CAGR of 11.7% in the first half of the forecast period.How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 195-page report you will receive 114 charts– all unavailable elsewhere.
The 195-page report provides clear detailed insight into the global drug discovery outsourcing market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Drug Discovery Outsourcing Market revenues forecasts to 2028
• Global Drug Discovery Outsourcing Market revenues forecast to 2028 by Service Type:
• Chemistry Services
• Biology Services
• Lead Optimisation
• Lead Identification & Screening
• Global Drug Discovery Outsourcing Market revenues forecast to 2028 by Regional and National Market:
• North America: U.S, Canada, Mexico
• Europe: Germany, France, UK, Italy, Spain, Russia, Rest of Europe
• Asia-Pacific: Japan, China, Australia, South Korea, India, Rest of Asia-Pacific
• LAMEA: Brazil, Saudi Arabia, Republic of South Africa, Rest of LAMEA

Each regional market is further segmented by submarket: chemistry services, biology services, lead optimisation, lead identification & screening.
• This report profiles and discusses the selected leading companies:
• Albany Molecular Research (AMRI)
• Aptuit, LLC
• Charles River Laboratories, Inc.
• Covance, Inc.
• Cyprotex plc
• Domainex
• Evotec AG
• GenScript
• IQVIA (QuintilesIMS)
• Laboratory Corporation of America
• Pharmaceutical Product Development (PPD)
• Selcia
• Viva Biotech
• WIL Research Laboratories
• WuXi AppTec
The report provides financial performance, service offerings, strategic moves & development, mergers & acquisitions.
• A SWOT analysis and Porter’s Five Forces Analysis of the Drug Discovery Outsourcing market.
• Key Questions Answered by this Report:
• How is the Drug Discovery Outsourcing Market evolving?
• What are the drivers and restraints for the growth of the Drug Discovery Outsourcing Market?
• How will each drug discovery outsourcing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2028?
• How will the market shares for each drug discovery outsourcing submarket develop to 2028?
• What is the value of the leading drug discovery outsourcing submarkets in important regions of the world?
• What will be the main driver for the overall market to 2028?
• How will the market shares of the national markets change by 2028 and which geographical region will lead the market by 2028?
• Who are the leading players and what are their prospects over the forecast period?
Visiongain’s study is intended for anyone requiring commercial analyses for the Global Drug Discovery Outsourcing Market. You find data, trends and predictions.
Buy our report today Global Drug Discovery Outsourcing Market Forecast to 2028: Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening.

【レポートの目次】

1. Report Overview
1.1 Global Drug Discovery Outsourcing Market Overview
1.2 Market Definition & Scope
1.3 Overview of Findings
1.4 Structure of the Report
1.5 Why You Should Read This Report?
1.6 Key Questions Answered by This Analytical Report
1.7 How This Report Delivers
1.8 Who is This Report For?
1.9 Methodology
1.9.1 Primary Research
1.9.2 Secondary Research
1.9.3 Market Evaluation & Forecasting Methodology
1.10 Frequently Asked Questions (FAQ)
1.11 Associated Visiongain Reports
1.12 About Visiongain

2. An Introduction to Drug Discovery Outsourcing
2.1 What is Outsourcing?
2.2 What is Drug Discovery Outsourcing?
2.3 Why Outsource Drug Discovery?
2.4 A Common Drug Discovery Model Includes Pharmaceutical Organizations Collaborating with Academia
2.5 The Outsource Model for Drug Development Increases Innovation
2.6 Outsourced Processes in Drug Discovery
2.7 Challenges with Drug Discovery Outsourcing
2.8 Emerging Markets are a Popular Destination for CROs
2.9 Strategic Partnerships to Acquisitions
2.10 Recent Drug Development Outsourcing Agreements

3. Global Drug Discovery Outsourcing Market and Service Area Submarkets: Market Forecast to 2028
3.1 Drug Discovery Outsourcing: Global Market Overview
3.2 The Global Drug Discovery Outsourcing Market: Revenue Forecast to 2028
3.3 Global Drug Discovery Outsourcing Market by Service Type: Revenue Forecast to 2028
3.4 Global Drug Discovery Outsourcing Market by Region: Revenue Forecast to 2028

4. Global Drug Discovery Outsourcing Market by Service Type: Forecast to 2028
4.1 The Global Drug Discovery Outsourcing Market by Service Type: Revenue Forecast to 2028
4.2 Chemistry Services
4.2.1 Libraries
4.2.2 Building Blocks
4.2.3 Compound Synthesis
4.2.4 Global Drug Discovery Outsourcing Market: Chemistry Services Revenue Forecast to 2028
4.3 Biology Services
4.3.1 Target Identification
4.3.2 Target Validation
4.3.3 Global Drug Discovery Outsourcing Market: Biology Services Revenue Forecast to 2028
4.4 Lead Optimisation
4.4.1 ADMET Screening: Prevents Late Stage Failure of Clinical Trials
4.4.2 Global Drug Discovery Outsourcing Market: Lead Optimisation Revenue Forecast to 2028
4.5 Lead Identification and Screening
4.5.1 Methods of Screening in Drug Discovery
4.5.2 Primary Screening
4.5.3 Global Drug Discovery Outsourcing Market: Lead Identification and Screening Revenue Forecast to 2028

5. Global Drug Discovery Outsourcing Market by Regional and National Market: Forecast to 2028
5.1 Drug Discovery Outsourcing Overview
5.2 The Leading National Markets in the Drug Discovery Outsourcing Market Forecast to 2028
5.3 North America
5.3.1 North America Drug Discovery Outsourcing Market by Service Type: Revenue Forecast to 2028
5.3.2 North America Drug Discovery Outsourcing Market by Country: Revenue Forecast to 2028
5.3.3 US Drug Discovery Outsourcing Market: Revenue Forecast to 2028
5.3.3.1 Canada Drug Discovery Outsourcing Market, Revenue Forecast to 2028
5.3.3.2 Mexico Drug Discovery Outsourcing Market: Revenue Forecast to 2028
5.4 Europe
5.4.1 Europe Drug Discovery Outsourcing Market by Service Type: Revenue Forecast to 2028
5.4.2 Europe Drug Discovery Outsourcing Market by Country: Revenue Forecast to 2028
5.4.2.1 Germany Drug Discovery Outsourcing Market: Revenue Forecast to 2028
5.4.2.2 France Drug Discovery Outsourcing Market: Revenue Forecast to 2028
5.4.2.3 United Kingdom Drug Discovery Outsourcing Market: Revenue Forecast to 2028
5.4.2.4 Italy Drug Discovery Outsourcing Market: Revenue Forecast to 2028
5.4.2.5 Spain Drug Discovery Outsourcing Market: Revenue Forecast to 2028
5.4.2.6 Russia Drug Discovery Outsourcing Market: Revenue Forecast, 2018-2028
5.5 Asia-Pacific
5.5.1 Asia-Pacific Drug Discovery Outsourcing Market by Service Type: Revenue Forecast to 2028
5.5.2 Asia-Pacific Drug Discovery Outsourcing Market by Country: Revenue Forecast to 2028
5.5.3 Japan Drug Discovery Outsourcing Market: Revenue Forecast to 2028
5.5.4 China Drug Discovery Outsourcing Market: Revenue Forecast to 2028
5.5.4.1 Challenges to China’s Growth
5.5.5 Australia Drug Discovery Outsourcing Market: Revenue Forecast to 2028
5.5.6 South Korea Drug Discovery Outsourcing Market: Revenue Forecast to 2028
5.5.7 India Drug Discovery Outsourcing Market: Revenue Forecast to 2028
5.6 LAMEA
5.6.1LAMEA Drug Discovery Outsourcing Market by Service Type: Revenue Forecast to 2028
5.6.2 LAMEA Drug Discovery Outsourcing Market by Country: Revenue Forecast to 2028
5.6.3 Brazil Drug Discovery Outsourcing Market: Revenue Forecast to 2028
5.6.4 Saudi Arabia Drug Discovery Outsourcing Market, Revenue Forecast to 2028
5.6.5 Republic of South Africa Drug Discovery Outsourcing Market: Revenue Forecast to 2028

6. Leading Companies in Drug Discovery Outsourcing Market
6.1 Drug Discovery Outsourcing: A Fragmented and Growing Marketplace
6.2 Characteristics of Leading Contract Research Organisations
6.2.1 A Highly Quality Workforce
6.2.2 Emphasis on Intellectual Property Protection
6.2.3 Long Term Working Relationship
6.2.4 Success in Project Completion
6.2.5 Internal Drug Discovery Programmes
6.3 Service Offerings of Leading Companies in the Drug Discovery Outsourcing Market
6.3.1 List of Key Participating Players in Drug Discovery Outsourcing Market
6.3.2 Albany Molecular Research (AMRI)
6.3.2.1 Company Overview
6.3.2.2 Historical Sales and Financial Performance, 2013-2016
6.3.2.3 AMRI’s Drug Discovery Services
6.3.2.4 Internal Portfolio of Drug Discovery and Development Programme Collaborations
6.3.3 Evotec AG
6.3.3.1 Evotec AG Financial Performance, 2013-2017
6.3.3.2 Evotec AG Sales Forecast, 2018-2028
6.3.3.3 Evotec AG Recent Strategic Moves & Development
6.3.3.3.1 Partnership with Boehringer Ingelheim Pharma
6.3.3.3.2 Collaboration with CHDI
6.3.3.3.3 Collaboration with MedImmune
6.3.3.3.4 Collaboration with UCB Pharma
6.3.3.3.5 Collaboration with Janssen
6.3.3.3.6 Partnership with Bayer Pharmaceuticals
6.3.3.3.7 Partnership with AstraZeneca
6.3.3.3.8 Partnership with Johnson & Johnson
6.3.3.3.9 Partnership with Sanofi
6.3.3.3.10 Extended Partnership with Evotec
6.3.3.3.11 Collaboration with TESARO, Inc.
6.3.3.3.12 Collaboration with Petra Pharma Corporation
6.3.3.3.13 Collaboration with Carna Biosciences, Incorporated
6.3.3.3.14 Collaboration with Celgene Corporation
6.3.3.3.15 Partnership with Sanofi
6.3.3.3.16 Collaboration with Bayer AG
6.3.3.3.17 Partnership with Novo Nordisk
6.3.3.3.18 Partnership with CENTOGENE AG
6.3.3.3.19 Collaboration with Almirall, S.A.
6.3.4 Aptuit
6.3.4.1 INDIGO: Accelerating Early Drug Candidates
6.3.4.2 Aptuit Clinical Trial Supplies
6.3.4.3 Strategic Partnerships, Acquisitions and Divestitures
6.3.4.3.1 Divestiture of Aseptic Clinical Manufacturing
6.3.4.3.2 Partnership with Siena Biotech
6.3.4.3.3 Aptuit’s Extended Partnership with GSK for Verona Centre
6.3.4.3.4 Partnership with Laurus Labs
6.3.4.3.5 Collaboration with Celgene Corporation
6.3.4.3.6 Partnership with Chronos Therapeutics
6.3.4.3.7 Partnership with Chiesi Farmaceutici
6.3.4.3.8 Collaboration with the Molecular Surgical Laboratory of Massachusetts General Hospital (MGH)
6.3.4.3.9 Partnership with SAMDI Tech, Inc.
6.3.4.3.10 Collaboration with Bioversys AG
6.3.4.3.11 Partnership with Regulus Therapeutics Inc.
6.3.5 Cyprotex
6.3.6 Charles River Laboratories
6.3.6.1 Historical Sales and Recent Financial Performance, 2013-2017
6.3.6.2 Strategies: Charles River Laboratories
6.3.6.2.1 Acquisition of Galapagos’ CRO Services Division (BioFocus and Argenta)
6.3.6.2.2 Acquisition of VivoPath
6.3.6.2.3 Acquisition of ChanTest
6.3.6.2.4 Partnership with The Milner Therapeutics Institute
6.3.6.2.5 Partnership with Chiesi Farmaceutici SpA
6.3.6.2.6 Partnership with Nimbus Therapeutics
6.3.6.2.7 Partnership with Microbiologics
6.3.6.2.8 Agreement with CAS
6.3.6.2.9 Partnership Extension with Eisai Co., Ltd.
6.3.6.2.10 Agreement with SenzaGen
6.3.6.2.11 Acquisition of Brains On-Line
6.3.6.2.12 Acquisition of KWS BioTest
6.3.6.2.13 Acquisition of MPI Research
6.3.6.2.14 Agreement with AstraZeneca
6.3.6.2.15 Partnership Extension with PathoQuest
6.3.6.3 Charles River Laboratories: Revenue and Financial Analysis, 2017
6.3.6.4 Charles River Laboratories Sales Forecast, 2018-2028
6.3.7 WIL Research Laboratories LLC
6.3.7.1 Focus on Preclinical Research
6.3.7.2 Acquisition of Midwest Bio Research
6.3.7.3 Acquisition of Ricerca Biosciences LLC
6.3.8 Covance (Acquired by Laboratory Corporation of America)
6.3.8.1 Covance: Historical Revenue and Financial Performance, 2010-2013
6.3.8.2 LabCorp Financial Performance, 2014-2017
6.3.8.3 Strategies: Covance
6.3.8.3.1 Agreement with Eli Lilly
6.3.8.3.2 Agreement with Kellogg Company
6.3.8.3.3 Early Stage Discovery Efforts
6.3.8.3.4 Agreement with Sanofi
6.3.8.3.5 Agreement with Bio Pontis Alliance
6.3.8.3.6 Agreement with Indiana Clinical and Translational Sciences Institute (CTSI)
6.3.8.3.7 Launch of Mobile Health Solutions
6.3.8.3.8 Business Expansion in the UK
6.3.8.3.9 Business Expansion in Precision Medicine
6.3.8.3.10 Acquisition of Chiltern
6.3.8.3.11 Introduced Dedicated Offering
6.3.8.3.12 Agreement with GlaxoSmithKline
6.3.8.3.13 Focused Unit on Biologic Drug Development
6.3.8.3.14 Acquisition of Sciformix Corporation
6.3.9 Domainex
6.3.9.1 Drug Pipeline
6.3.9.2 TBK1/ IKKε-Inhibitors
6.3.9.3 Methyltransferase (KMTS) Inhibitors
6.3.10 GenScript Biotech Corporation
6.3.10.1 GenScript: Revenue and Financial Analysis, 2017
6.3.10.2 GenScript: Agreements and Partnerships
6.3.11 Pharmaceutical Product Development (PPD)
6.3.11.1 PPD: Agreements, Strategic Partnerships and Private Merger
6.3.11.1.1 Partnership with GSK
6.3.11.1.2 Partnership with Elan
6.3.11.1.3 Acquisition of Acurian
6.3.11.1.4 Collaboration with Charité–Universitätsmedizin Berlin
6.3.11.1.5 Acquisition of RCT Logic’s Exclusive License
6.3.11.1.6 Partnership with ERT
6.3.11.1.7 Partnership with Shin Nippon Biomedical Laboratories Ltd.
6.3.11.1.8 Collaboration with HealthCore, Inc.
6.3.11.1.9 Collaboration with CISYS LifeSciences
6.3.11.1.10 Collaboration with Moderna Therapeutics
6.3.11.1.11 Acquisition of Evidera
6.3.11.1.12 Collaboration with Frenova Renal Research
6.3.11.1.13 Collaboration with Quotient Sciences
6.3.12 QuintilesIMS (IQVIA)
6.3.12.1 QuintilesIMS: Historical Revenue and Financial Performance, 2013-2017
6.3.12.2 QuintilesIMS: Strategic moves & developments
6.3.12.2.1 Development Deal with Merck
6.3.12.2.2 QuintilesIMS: Acquisition of Advion Bioanalytical Labs
6.3.12.2.3 QuintilesIMS: Shedding Jobs
6.3.12.2.4 Merger with IMS Health
6.3.12.3 QuintilesIMS Sales Forecast, 2017-2028
6.3.13 Selcia
6.3.13.1 A Strong Natural Product Chemistry Track Record
6.3.13.2 Selcia Product Portfolio
6.3.13.3 Selcia Strategic Moves
6.3.13.3.1 Collaboration with Cantab
6.3.13.3.2 Initiative with the University of Edinburgh
6.3.13.3.3 Collaboration with Janssen Pharmaceuticals Inc.
6.3.13.3.4 Collaboration with Gilead Sciences, Inc.
6.3.13.3.5 Collaboration with Parkinson’s UK
6.3.14 Viva Biotech (Shanghai) Ltd.
6.3.15 WuXi Apptec
6.3.15.1 WuxiTec Services & Solutions Offerings
6.3.15.2 WuXiAppTec: Historical Revenue and Financial Performance, 2010-2014
6.3.15.3 WuxiTec: Strategic Moves
6.3.15.3.1 Acquisition of Next CODE Health
6.3.15.3.2 Collaboration with Gilead Sciences, Inc.
6.3.15.3.3 Collaboration with Eli Lilly and Company
6.3.15.3.4 Acquisition of Crelux GmbH
6.3.15.3.5 Collaboration with Pelago Bioscience
6.3.15.3.6 Partnership with AutoGenomics
6.3.15.3.7 Acquisition of HD Biosciences
6.3.15.3.8 Acquisition of ResearchPoint Global
6.3.15.3.9 Partnership with Mayo Clinic
6.3.15.3.10 Collaboration with Regulus Therapeutics Inc.
6.3.15.3.11 Business Expansion in the U.S.
6.3.15.3.12 Partnership with Antengene Corporation

7. Qualitative Analysis of the Drug Discovery Outsourcing Market
7.1 Drivers and Restraints in the Drug Discovery Outsourcing Market
7.2 SWOT Analysis of the Drug Discovery Outsourcing Market, 2018-2028
7.2.1 Strengths
7.2.1.1 Cost Reduction: A Central Driver for Outsourcing
7.2.1.2 Accelerating the Discovery of Drug Candidates
7.2.1.3 Growth of Virtual Pharmaceutical Companies
7.2.1.4 Reduction in R&D capacity Within Big Pharma
7.2.2 Weaknesses
7.2.2.1 Slowing Trajectory of Growth for R&D Spending
7.2.2.2 Increasingly Saturated Market Requires Companies to Quickly Evolve
7.2.3 Opportunities
7.2.3.1 The Available Scope for the Expansion of CROs
7.2.3.2 Targeted Therapies: Advances in Biologics and Orphan Drugs
7.2.3.3 Increasing Development of Biologics and Biosimilars
7.2.4 Threats
7.2.4.1 A Competitive Market is Increasing Consolidation
7.2.4.2 Threat of Private Public Alliances
7.2.4.3 Intellectual Property Leaks
7.2.4.4 Challenges of Technology Transfer
7.3 Porter’s Five Forces Analysis of the Drug Discovery Outsourcing Market
7.3.1 Threat of New Entrants: Medium
7.3.2 Power of Suppliers: Medium
7.3.3 Threat of Substitutes: Medium
7.3.4 Power of Buyers: High
7.3.5 Rivalry Among Competitors: High

8. Conclusion
8.1 Market Overview
8.2 Lead Optimisation will be the Fastest Growing Sector
8.3 The Drug Discovery Outsourcing Market in Emerging Market Shows Huge Gains
8.4 Continued Growth in Alliances and Collaborations
8.5 Concluding Remarks

Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain report evaluation form

List of Tables
Table 2.1 Indication of Functions Outsourced in the Different Stages of the Drug R&D Process, 2017
Table 2.2 Selected Drug Discovery Outsourcing Alliances, 2013-2018
Table 3.1 PhMRA’s Historical Estimate for its Member’s Total R&D Spending ($bn), 1980–2016
Table 3.2 Global Drug Discovery Outsourcing Market Forecast: Revenue ($m), AGR (%), and CAGR (%) 2018-2028
Table 3.3 Global Drug Discovery Outsourcing Market by Service Type: Revenue ($mn), AGR (%) and CAGR (%) 2017-2028
Table 3.4 Global Drug Discovery Outsourcing Market by Leading Nationals: Revenue ($m), AGR (%) and CAGR (%), 2018-2028
Table 4.1 Global Drug Discovery Outsourcing Market: Revenue ($m), Revenue Share (%) by Service Type, 2017, 2023, 2028
Table 4.2 Global Drug Discovery Outsourcing Market: Chemistry Services Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 4.3 Global Drug Discovery Outsourcing Market: Biology Services Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 4.4 Global Drug Discovery Outsourcing Market: Lead Optimisation Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 4.5: Selected Source for Lead Compounds
Table 4.6 Global Drug Discovery Outsourcing Market: Lead Identification and Screening Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.1 Global Drug Discovery Outsourcing Market: Revenue ($m), Revenue Share (%) by Region, 2017, 2023, 2028
Table 5.2 North America Drug Discovery Outsourcing Market by Service Type: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.3 North America Drug Discovery Outsourcing Market by Country: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.4 US Drug Discovery Outsourcing Market: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.5: Canada Drug Discovery Outsourcing Market: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.6 Mexico Drug Discovery Outsourcing Market: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.7 Europe Drug Discovery Outsourcing Market by Service Type: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.8 Europe Drug Discovery Outsourcing Market by Country: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.9 Germany Drug Discovery Outsourcing Market: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.10 France Drug Discovery Outsourcing Market: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.11: United Kingdom Drug Discovery Outsourcing Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028
Table 5.12: Italy Drug Discovery Outsourcing Market: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.13: Spain Drug Discovery Outsourcing Market: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.14: Russia Drug Discovery Outsourcing Market: Revenue ($m), AGR (%) and CAGR (%) 2017-2028
Table 5.15: Asia-Pacific Drug Discovery Outsourcing Market by Service Type: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.16: Asia-Pacific Drug Discovery Outsourcing Market by Country: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.17: Japan Drug Discovery Outsourcing Market: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.18: China Drug Discovery Outsourcing Market: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.19: Australia Drug Discovery Outsourcing Market: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.20: South Korea Drug Discovery Outsourcing Market: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.21: India Drug Discovery Outsourcing Market: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.22: LAMEA Drug Discovery Outsourcing Market by Service Type: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.23: LAMEA Drug Discovery Outsourcing Market by Country: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.24: Brazil Drug Discovery Outsourcing Market: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.25: Saudi Arabia Drug Discovery Outsourcing Market: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 5.26: Republic of South Africa Drug Discovery Outsourcing Market: Revenue ($m), AGR (%) and CAGR (%) 2018-2028
Table 6.1: List of Key Participating Players
Table 6.2: Albany Molecular Research (AMRI): Historical Revenue ($m), 2013-2016
Table 6.3: AMRI: Service Offerings and Descriptions, 2017
Table 6.4: Evotec: Revenue and R&D Expenses ($m), 2013-2017
Table 6.5: Evotec AG Forecast: Revenue ($m), AGR (%), CAGR (%), 2017-2028
Table 6.6: Selected Cyprotex Partnerships, 2015
Table 6.7: Charles River Laboratories: Historical Revenue ($m), 2013-2017
Table 6.8: Charles River Laboratories: Revenue ($m) by Segment, 2015-2017
Table 6.9: Charles River Laboratories: Revenue & %Change, 2015-2017
Table 6.10: Charles River Laboratories Forecast: Revenue ($m), AGR (%), CAGR (%), 2018-2028
Table 6.11: Covance: Historical Revenue ($bn), 2010-2013
Table 6.12: LabCorp: Historical Revenue ($m), 2014-2017
Table 6.13: Domainex Selected Collaborations
Table 6.14: Domainex: Drug Pipeline by Indication, 2018
Table 6.15: GenScript: Business Segments
Table 6.16: GenScript: Revenue by Business Segments ($m, %), 2016 & 2017
Table 6.17: QuintilesIMS: Revenue ($m) & AGR (%), 2013-2017
Table 6.18: QuintilesIMS Forecast: Revenue ($bn), AGR (%), CAGR (%), 2017-2028
Table 6.19: Viva Biotech: Service Offerings
Table 6.20: WuXi AppTec: Historical Revenue ($m), By Business Segments, 2010-2014
Table 7.1 SWOT Analysis of the Drug Discovery Outsourcing Industry, 2017-2027
Table 8.1: The Global Drug Discovery Outsourcing Market Forecast: Revenue ($m), CAGR (%), 2017, 2023 & 2028
Table 8.2: Global Drug Discovery Outsourcing Market, Revenue ($m) by Service Type, 2017, 2023, 2028

List of Figures
Figure 2.1 Selected Tasks being Outsourced in the Pharma Industry, 2017
Figure 2.2 Stages of the Drug Development Cycle
Figure 3.1 PhMRA’s Historical Estimate for its Member’s Total R&D Spending ($bn), 2000–2016
Figure 3.2 Attrition Rate of Compounds at the Developmental Stages
Figure 3.3 Global Drug Discovery Outsourcing Market: Revenue ($m), AGR (%), 2018-2028
Figure 4.1 The Global Drug Discovery Outsourcing Market: Market Shares (%) by Service Type, 2018
Figure 4.2 The Global Drug Discovery Outsourcing Market: Market Shares (%) by Service Type, 2023
Figure 4.3 The Global Drug Discovery Outsourcing Market: Market Shares (%) by Service Type, 2028
Figure 4.4 Global Drug Discovery Outsourcing Market Revenue ($m) by Service Type, 2018-2028
Figure 4.5 Global Drug Discovery Outsourcing Market: Chemistry Services Revenue ($m), AGR (%), 2018-2028
Figure 4.6 Global Drug Discovery Outsourcing Market: Biology Services Revenue ($m), AGR (%), 2018-2028
Figure 4.7: An Overview of ADMET Screening in Drug Discovery
Figure 4.8 Global Drug Discovery Outsourcing Market: Lead Optimisation Revenue ($m), AGR (%), 2017-2028
Figure 4.8 Typical Steps in the Lead Screening Process
Figure 4.9 Global Drug Discovery Outsourcing Market: Lead Identification and Screening Revenue ($m), AGR (%), 2018-2028
Figure 5.1 The Global Drug Discovery Outsourcing Market: Market Shares (%) by Region, 2017
Figure 5.2 The Global Drug Discovery Outsourcing Market: Market Shares (%) by Region, 2023
Figure 5.3. The Global Drug Discovery Outsourcing Market: Market Shares (%) by Region, 2028
Figure 5.4 Global Drug Discovery Outsourcing Market Revenue ($m) by Leading Nationals, 2018-2028
Figure 5.5 US Drug Discovery Outsourcing Market: Revenue ($m), AGR (%), 2018-2028
Figure 5.6: Canada Drug Discovery Outsourcing Market: Revenue ($m), AGR (%), 2018-2028
Figure 5.7 Mexico Drug Discovery Outsourcing Market: Revenue ($m), AGR (%), 2018-2028
Figure 5.8 Germany Drug Discovery Outsourcing Market: Revenue ($m), AGR (%), 2018-2028
Figure 5.9: France Drug Discovery Outsourcing Market: Revenue ($m), AGR (%), 2018-2028
Figure 5.10: United Kingdom Drug Discovery Outsourcing Market: Revenue ($m), AGR (%), 2018-2028
Figure 5.11: Italy Drug Discovery Outsourcing Market: Revenue ($m), AGR (%), 2018-2028
Figure 5.12: Spain Drug Discovery Outsourcing Market: Revenue ($m), AGR (%), 2018-2028
Figure 5.13: Russia Drug Discovery Outsourcing Market: Revenue ($m), AGR (%), 2018-2028
Figure 5.14: Japan Drug Discovery Outsourcing Market: Revenue ($m), AGR (%), 2017-2028
Figure 5.15: China Drug Discovery Outsourcing Market: Revenue ($m), AGR (%), 2018-2028
Figure 5.16: Australia Drug Discovery Outsourcing Market: Revenue ($m), AGR (%), 2018-2028
Figure 5.17: South Korea Drug Discovery Outsourcing Market: Revenue ($m), AGR (%), 2018-2028
Figure 5.18: India Drug Discovery Outsourcing Market: Revenue ($m), AGR (%), 2018-2028
Figure 5.19: Brazil Drug Discovery Outsourcing Market: Revenue ($m), AGR (%), 2018-2028
Figure 5.20: Saudi Arabia Drug Discovery Outsourcing Market: Revenue ($m), AGR (%), 2018-2028
Figure 5.21: Republic of South Africa Drug Discovery Outsourcing Market: Revenue ($m), AGR (%), 2018-2028
Figure 6.1: Albany Molecular Research (AMRI): Historical Revenue ($m), 2013-2016
Figure 6.2: Evotec AG Forecast: Revenue ($m), AGR (%), 2017-2028
Figure 6.3: Charles River Laboratories: Historical Revenue ($m), 2013-2017
Figure 6.4: Charles River Laboratories: Revenue Share (%) by Segment, 2017
Figure 6.5: Charles River Laboratories: Revenue & %Change, 2015-2017
Figure 6.6: Charles River Laboratories Forecast: Revenue ($m), AGR (%), 2017-2028
Figure 6.7: Covance: Historical Revenue ($m), 2010-2013
Figure 6.8: Covance: Revenue Share (%) by Segment, 2013
Figure 6.9: LabCorp: Historical Revenue ($m), 2014-2017
Figure 6.10: LabCorp: Revenue Share (%) by Segment, 2017
Figure 6.11: GenScript: Revenue by Business Segments (%), 2017
Figure 6.12: QuintilesIMS: Revenue ($m), 2013-2017
Figure 6.13: QuintilesIMS Forecast: Revenue ($bn), AGR (%), 2017-2028
Figure 7.1: The Drug Discovery Outsourcing Market: Drivers and Restraints, 2018-2028
Figure 7.2: Porter’s Five Forces Analysis of the Companion Diagnostics Market, 2018-2028
Figure 8.1: The Global Drug Discovery Outsourcing Market Forecast: Revenue ($m), 2017, 2023, 2028
Figure 8.2: The Global Drug Discovery Outsourcing Market Forecast: Revenue ($m) by Service Type, 2017, 2023, 2028

★調査レポート[創薬アウトソーシングの世界市場予測2019-2029] ( Global Drug Discovery Outsourcing Market Forecast to 2028 / VGN906173) 販売に関する免責事項
[創薬アウトソーシングの世界市場予測2019-2029] ( Global Drug Discovery Outsourcing Market Forecast to 2028 / VGN906173) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆